Interventions to Prevent Falls. PRECAISAL Study

Interventions to Prevent Falls in Elderly People Who Live at Home. PRECAISAL Study

This study aims to guide older people living in the community on appropriate strategies within a fall prevention program. This program is aimed at training in physical exercises carried out through group workshops or at preventing risk situations at home.

Study Overview

Detailed Description

Two-arm, non-blind, non-inferiority experimental design. Multicenter, randomized trial.

The study tries to assess whether a group intervention following the principles of the LiFE program is no less effective than individual intervention in reducing the incidence of falls.

Study Type

Interventional

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

  • Name: Emiliano Rodríguez-Sánchez
  • Phone Number: 923231859
  • Email: emiliano@usal.es

Study Locations

      • Salamanca, Spain, 37005
        • Infosalud

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

70 years and older (Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Older than 70 years
  • Live at your address
  • Are at risk of falls
  • Timed Up and Go Test time timed ≥ 12 seconds
  • Able to walk 200 meters without personal assistance
  • Speak and read in Spanish

Exclusion Criteria:

  • Perform moderate to vigorous physical activity> 150 min / week in the last 3 months
  • Present any of the following medical conditions:

    • Heart failure (New York Heart Association class III and IV)
    • Recent stroke (<6 months)
    • Parkinson's disease
    • In active cancer treatment (last 6 months)
    • Class III and IV chronic obstructive pulmonary disease
    • Unstable fracture of the lower limb
    • Lower limb amputated
    • Treatment for less than 6 months of depression
    • Uncontrolled resting blood pressure of a systolic pressure> 160 or a diastolic pressure> 100 or more
    • Not being available for home visits within 11 weeks of the initial assessment: having planned trips or transfers of more than 2 months within the first 6 months of the study
    • Moderate to severe cognitive impairment (Mini Mental cognitive assessment <23)
    • Current participation in another scientific intervention trial.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Individual treatment
The strength and balance activities of the LiFE program will be carried out. Participants will receive 7 home visits and will be given the support material for the manual (diptychs, pictures, etc.).
Participants will receive 7 home visits to implement the program.
Experimental: Groupal treatment
The strength and balance activities of the LiFE program will be carried out. Participants will be invited to participate in groups of about 8 - 12 people in community venues.
Subjects will participate in groups of about 8 - 12 to implement the program.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of falls
Time Frame: 6 months
Number of falls in relation to the degree of physical activity
6 months
Physical activity
Time Frame: 9 days
It will be evaluated with a digital pedometer
9 days
Cost-effectiveness
Time Frame: 6 months
Evaluated by the incremental cost-effectiveness ratio
6 months
Health effects
Time Frame: 6 months
They are measured using quality-adjusted life years (QALYs) based on the EQ-5D-5
6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fear of falling
Time Frame: 6 months
It will be assessed using the Short Falls International Scale of Efficacy. This scale measures of "concerns about falling". This scale has 7 items with a Likert scale with 4 options: 1) not at all concerned, 2) somewhat concerned, 3) fairly concerned, and 4) very concerned.
6 months
Adherence to exercise
Time Frame: 6 months
It will be assessed using the Exercise Adherence Rating Scale (EARS). This scale is composed of 16 items and they were scored using a 5-point Likert scale (0 = completely agree to 4 = completely disagree) with a possible summed score range from 0 to 64.
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Luis García-Ortiz, Primary Health Care Research Unit

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 2, 2020

Primary Completion (Actual)

April 1, 2020

Study Completion (Actual)

May 28, 2023

Study Registration Dates

First Submitted

September 27, 2021

First Submitted That Met QC Criteria

September 27, 2021

First Posted (Actual)

October 7, 2021

Study Record Updates

Last Update Posted (Estimated)

June 13, 2023

Last Update Submitted That Met QC Criteria

June 11, 2023

Last Verified

June 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • GRS 1985/B/19

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Old Age; Debility

Clinical Trials on Individual treatment

3
Subscribe